Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025, and recent corporate updates.

TIC Solutions, Inc. (NYSE: TIC) ("TIC Solutions" or the "Company"), a leading provider of critical asset integrity solutions ...

Microsoft's .NET 10 release highlights AI integration through the new Microsoft Agent Framework and related extensions, ...

Generated revenue of $35 million, driven by strong performance of the foundational PAC businessReported Adjusted EBITDA of $5.2 million, ...

Q3 2025 Earnings Call Transcript November 4, 2025 Exagen Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, ...

Tata Motors PV share price slips nearly 2% ahead of the Q2 results announcement. Tata Motors PV stock was trading at ₹ 391.60 ...

Get key insights from Insight Molecular Diagnostics' Q3 2025 earnings call—FDA progress, $1B market outlook, and innovations in transplant testing.

Thank you, operator, and good afternoon, everyone. Thank you for joining us today for Research Solutions First Quarter Fiscal Year 2026 Earnings Call. On the call with me today are Roy W. Olivier, ...

Adaptive Biotechnologies Corp (ADPT) reports a 102% revenue increase and improved financial guidance, showcasing robust ...

Q1 2026 Earnings Call Transcript November 13, 2025Research Solutions, Inc. reports earnings inline with expectations.

Clinical Data—SIMPLIFY Study -- Updated analysis increased Gallery's PPV in symptomatic patients to 84.2% after long-term ...